178 related articles for article (PubMed ID: 30971809)
1. A genome-wide association study of tramadol metabolism from post-mortem samples.
Wendt FR; Rahikainen AL; King JL; Sajantila A; Budowle B
Pharmacogenomics J; 2020 Feb; 20(1):94-103. PubMed ID: 30971809
[TBL] [Abstract][Full Text] [Related]
2. Post-mortem SNP analysis of CYP2D6 gene reveals correlation between genotype and opioid drug (tramadol) metabolite ratios in blood.
Levo A; Koski A; Ojanperä I; Vuori E; Sajantila A
Forensic Sci Int; 2003 Jul; 135(1):9-15. PubMed ID: 12893130
[TBL] [Abstract][Full Text] [Related]
3. Concentrations of tramadol and O-desmethyltramadol enantiomers in different CYP2D6 genotypes.
Stamer UM; Musshoff F; Kobilay M; Madea B; Hoeft A; Stuber F
Clin Pharmacol Ther; 2007 Jul; 82(1):41-7. PubMed ID: 17361124
[TBL] [Abstract][Full Text] [Related]
4. Pharmacokinetics of tramadol enantiomers and their respective phase I metabolites in relation to CYP2D6 phenotype.
García-Quetglas E; Azanza JR; Sádaba B; Muñoz MJ; Gil I; Campanero MA
Pharmacol Res; 2007 Feb; 55(2):122-30. PubMed ID: 17175164
[TBL] [Abstract][Full Text] [Related]
5. Supervised Classification of CYP2D6 Genotype and Metabolizer Phenotype With Postmortem Tramadol-Exposed Finns.
Wendt FR; Novroski NMM; Rahikainen AL; Sajantila A; Budowle B
Am J Forensic Med Pathol; 2019 Mar; 40(1):8-18. PubMed ID: 30507617
[TBL] [Abstract][Full Text] [Related]
6. Sequencing CYP2D6 for the detection of poor-metabolizers in post-mortem blood samples with tramadol.
Fonseca S; Amorim A; Costa HA; Franco J; Porto MJ; Santos JC; Dias M
Forensic Sci Int; 2016 Aug; 265():153-9. PubMed ID: 26926096
[TBL] [Abstract][Full Text] [Related]
7. Near-fatal tramadol cardiotoxicity in a CYP2D6 ultrarapid metabolizer.
Elkalioubie A; Allorge D; Robriquet L; Wiart JF; Garat A; Broly F; Fourrier F
Eur J Clin Pharmacol; 2011 Aug; 67(8):855-8. PubMed ID: 21691803
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of CYP2D6-mediated tramadol O-demethylation in methadone but not buprenorphine maintenance patients.
Coller JK; Michalakas JR; James HM; Farquharson AL; Colvill J; White JM; Somogyi AA
Br J Clin Pharmacol; 2012 Nov; 74(5):835-41. PubMed ID: 22369095
[TBL] [Abstract][Full Text] [Related]
9. Effects of the CYP2D6 gene duplication on the pharmacokinetics and pharmacodynamics of tramadol.
Kirchheiner J; Keulen JT; Bauer S; Roots I; Brockmöller J
J Clin Psychopharmacol; 2008 Feb; 28(1):78-83. PubMed ID: 18204346
[TBL] [Abstract][Full Text] [Related]
10. Loss-of-function polymorphisms in the organic cation transporter OCT1 are associated with reduced postoperative tramadol consumption.
Stamer UM; Musshoff F; Stüber F; Brockmöller J; Steffens M; Tzvetkov MV
Pain; 2016 Nov; 157(11):2467-2475. PubMed ID: 27541716
[TBL] [Abstract][Full Text] [Related]
11. Covariates of tramadol disposition in the first months of life.
Allegaert K; van den Anker JN; de Hoon JN; van Schaik RH; Debeer A; Tibboel D; Naulaers G; Anderson BJ
Br J Anaesth; 2008 Apr; 100(4):525-32. PubMed ID: 18303070
[TBL] [Abstract][Full Text] [Related]
12. Pharmacogenetic aspects of tramadol pharmacokinetics and pharmacodynamics after a single oral dose.
Bastami S; Haage P; Kronstrand R; Kugelberg FC; Zackrisson AL; Uppugunduri S
Forensic Sci Int; 2014 May; 238():125-32. PubMed ID: 24709712
[TBL] [Abstract][Full Text] [Related]
13. The effects of tramadol on static and dynamic pupillometry in healthy subjects--the relationship between pharmacodynamics, pharmacokinetics and CYP2D6 metaboliser status.
Fliegert F; Kurth B; Göhler K
Eur J Clin Pharmacol; 2005 Jun; 61(4):257-66. PubMed ID: 15906019
[TBL] [Abstract][Full Text] [Related]
14. Effect of the cytochrome P450 2D6*10 genotype on the pharmacokinetics of tramadol in post-operative patients.
Xu J; Zhang XC; Lv XQ; Xu YY; Wang GX; Jiang B; Cai L; Cai XJ
Pharmazie; 2014 Feb; 69(2):138-41. PubMed ID: 24640604
[TBL] [Abstract][Full Text] [Related]
15. Analgesic effects and assays of controlled-release tramadol and o-desmethyltramadol in cancer patients with pain.
Leppert W; Mikolajczak P
Curr Pharm Biotechnol; 2011 Feb; 12(2):306-12. PubMed ID: 21050160
[TBL] [Abstract][Full Text] [Related]
16. Population pharmacokinetic modeling of tramadol and its O-desmethyl metabolite in plasma and breast milk.
Salman S; Sy SK; Ilett KF; Page-Sharp M; Paech MJ
Eur J Clin Pharmacol; 2011 Sep; 67(9):899-908. PubMed ID: 21394525
[TBL] [Abstract][Full Text] [Related]
17. Ticlopidine inhibits both O-demethylation and renal clearance of tramadol, increasing the exposure to it, but itraconazole has no marked effect on the ticlopidine-tramadol interaction.
Hagelberg NM; Saarikoski T; Saari TI; Neuvonen M; Neuvonen PJ; Turpeinen M; Scheinin M; Laine K; Olkkola KT
Eur J Clin Pharmacol; 2013 Apr; 69(4):867-75. PubMed ID: 23099620
[TBL] [Abstract][Full Text] [Related]
18. Assessment of tramadol pharmacokinetics in correlation with CYP2D6 and clinical symptoms.
Ahmadimanesh M; Naeini MB; Rouini MR; Shadnia S; Ghazi-Khansari M
Drug Metab Pers Ther; 2020 Jun; 35(2):. PubMed ID: 32681776
[TBL] [Abstract][Full Text] [Related]
19. Concordance between tramadol and dextromethorphan parent/metabolite ratios: the influence of CYP2D6 and non-CYP2D6 pathways on biotransformation.
Abdel-Rahman SM; Leeder JS; Wilson JT; Gaedigk A; Gotschall RR; Medve R; Liao S; Spielberg SP; Kearns GL
J Clin Pharmacol; 2002 Jan; 42(1):24-9. PubMed ID: 11808821
[TBL] [Abstract][Full Text] [Related]
20. Respiratory depression with tramadol in a patient with renal impairment and CYP2D6 gene duplication.
Stamer UM; Stüber F; Muders T; Musshoff F
Anesth Analg; 2008 Sep; 107(3):926-9. PubMed ID: 18713907
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
